Please activate JavaScript!
Please install Adobe Flash Player, click here for download

Journal of Oral Science & Rehabilitation No. 1, 2017

G u i d e d b o n e r e g e n e r a t i o n i n p e r i i m p l a n t i t i s t h e r a p y Fig. 6 Pocket depth after 49 and more months compared with pocket depth at 12 months in all treated implants. (m = mesial; v = vestibular; d = distal; o = oral; 12 months: n = 158; 49 and more months: n = 16). Fig. 7 Number of implants showing BOP before periimplantitis therapy and at recall visits up to 49 and more months after the start of the therapy. (n = 8–158). Fig. 6 Fig. 7 after the periimplantitis therapy and in 73.1% of 26 implants evaluated with long-term data available 49–56 months post-therapy (Fig. 7). During the follow-up period, one treated im- plant had to undergo additional gingivectomy and eight repeated implantoplasties. Despite treatment, 15 implants had to be explanted during the follow-up period (9.49%), three of these in patients with diabetes, one in a smoker and two in which the therapy included an intraosseous defect treatment. Evaluation of the original data files for the 158 treated implants established that bone aug- mentation procedures using a DBBM and an 38 Volume 3 | Issue 1/2017 Journal of Oral Science & Rehabilitation

Pages Overview